SCHEMBL8798762

SCHEMBL8798762

CCOC(=O)C(CCC(N)C(=O)OC(C)(C)C)(OCc1cccnc1)C(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.41
CYP3A4 P08684 4/20 0.38
GPR119 Q8TDV5 1/20 0.37
SLC1A5 Q15758 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ADA P00813 1/20 0.35
CTSL P07711 2/20 0.35
CTSB P07858 2/20 0.35
GRM2 Q14416 1/20 0.35
RIPK1 Q13546 1/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
KDM4E B2RXH2 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8798260 0.91 LTA4H (0.38) LTA4HCYP3A4GPR119MAPK1SMN1; SMN2
SCHEMBL8799769 0.88 LTA4H (0.41) LTA4HCYP3A4GPR119MAPK1ALDH1A1
SCHEMBL8329546 0.87 LTA4H (0.52) LTA4HSMN1; SMN2ALDH1A1KMT2A
SCHEMBL8799646 0.84 MAPK1 (0.37) LTA4HCYP3A4MAPK1SMN1; SMN2GRM2
SCHEMBL8798842 0.82 DPP4 (0.40) LTA4HCYP3A4GPR119MAPK1SMN1; SMN2
SCHEMBL8800040 0.82 LTA4H (0.42) LTA4HSLC1A5MAPK1SMN1; SMN2ALDH1A1
SCHEMBL8803290 0.80 LTA4H (0.46) LTA4HSMN1; SMN2ALDH1A1
SCHEMBL8798766 0.79 CYP3A4 (0.37) CYP3A4GPR119SLC1A5MAPK1SMN1; SMN2
SCHEMBL8798754 0.79 CYP3A4 (0.57) CYP3A4ALDH1A1KMT2AKDM4E
SCHEMBL8799063 0.78 LTA4H (0.45) LTA4HSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed